Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
09 2019
Historique:
received: 02 11 2018
accepted: 14 01 2019
pubmed: 7 2 2019
medline: 6 2 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Lanosterol synthase (LSS) gene was initially described in families with extensive congenital cataracts. Recently, a study has highlighted LSS associated with hypotrichosis simplex. We expanded the phenotypic spectrum of LSS to a recessive neuroectodermal syndrome formerly named alopecia with mental retardation (APMR) syndrome. It is a rare autosomal recessive condition characterized by hypotrichosis and intellectual disability (ID) or developmental delay (DD), frequently associated with early-onset epilepsy and other dermatological features. Through a multicenter international collaborative study, we identified LSS pathogenic variants in APMR individuals either by exome sequencing or LSS Sanger sequencing. Splicing defects were assessed by transcript analysis and minigene assay. We reported ten APMR individuals from six unrelated families with biallelic variants in LSS. We additionally identified one affected individual with a single rare variant in LSS and an allelic imbalance suggesting a second event. Among the identified variants, two were truncating, seven were missense, and two were splicing variants. Quantification of cholesterol and its precursors did not reveal noticeable imbalance. In the cholesterol biosynthesis pathway, lanosterol synthase leads to the cyclization of (S)-2,3-oxidosqualene into lanosterol. Our data suggest LSS as a major gene causing a rare recessive neuroectodermal syndrome.

Identifiants

pubmed: 30723320
doi: 10.1038/s41436-019-0445-x
pii: S1098-3600(21)04993-5
doi:

Substances chimiques

Lanosterol 1J05Z83K3M
oxidosqualene 2Y5JJZ8E4W
Squalene 7QWM220FJH
Cholesterol 97C5T2UQ7J
Intramolecular Transferases EC 5.4.-
lanosterol synthase EC 5.4.99.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2025-2035

Auteurs

Thomas Besnard (T)

CHU de Nantes, Service de Génétique Médicale, Nantes, France. thomas.besnard@chu-nantes.fr.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France. thomas.besnard@chu-nantes.fr.

Natacha Sloboda (N)

INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.

Alice Goldenberg (A)

Department of Genetics, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.

Sébastien Küry (S)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Benjamin Cogné (B)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Flora Breheret (F)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.

Eva Trochu (E)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.

Solène Conrad (S)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.

Marie Vincent (M)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Wallid Deb (W)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Xavier Balguerie (X)

Department of Dermatology, University Hospital Center of Rouen, Rouen, France.

Sébastien Barbarot (S)

CHU de Nantes, Department of Dermatology, Nantes, France.

Geneviève Baujat (G)

Department of Medical Genetics, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, IMAGINE Institute, Necker Enfants Malades Hospital, Paris, France.

Tawfeg Ben-Omran (T)

Section of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

Anne-Claire Bursztejn (AC)

Dermatology department, hôpital Brabois, Vandœuvre-Lès, Vandœuvre-lès-Nancy, France.

Virginie Carmignac (V)

Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.

Alexandre N Datta (AN)

Department of Pediatric Neurology and Developmental Medicine, University of Basel Children's Hospital (UKBB), Basel, Switzerland.

Aline Delignières (A)

CH Auray-Vannes, Hôpital Bretagne Atlantique, Service de Pediatrie, Vannes, France.

Laurence Faivre (L)

Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.

Betty Gardie (B)

L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France.

Jean-Louis Guéant (JL)

INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.

Paul Kuentz (P)

Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.

Marion Lenglet (M)

L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France.

Marie-Cécile Nassogne (MC)

Pediatric Neurology Unit, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium.

Vincent Ramaekers (V)

Center of Autism and Department of Genetics, University Hospital Liege (CHU), Liège, Belgium.

Rhonda E Schnur (RE)

GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.

Yue Si (Y)

GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.

Erin Torti (E)

GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.

Julien Thevenon (J)

Centre de Génétique, Hôpital Couple-Enfant, CHU de Grenoble-Alpes, La Tronche, France.

Pierre Vabres (P)

Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.

Lionel Van Maldergem (L)

Centre de génétique humaine, Université de Franche-Comté, Besançon, France.
Integrative and Cognitive Neurosciences Research Unit EA481, University of Franche-Comté, Besançon, France.

Dorothea Wand (D)

Department Medical Genetic and Pathology, University Hospital of Basel (USB), Basel, Switzerland.

Arnaud Wiedemann (A)

INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.

Bertrand Cariou (B)

L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Richard Redon (R)

L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Antonin Lamazière (A)

Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, France.

Stéphane Bézieau (S)

CHU de Nantes, Service de Génétique Médicale, Nantes, France.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.

Francois Feillet (F)

INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.

Bertrand Isidor (B)

CHU de Nantes, Service de Génétique Médicale, Nantes, France. bertrand.isidor@chu-nantes.fr.
L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France. bertrand.isidor@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH